This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Zhejiang Ausun Pharmaceutical Co., Ltd.. Active years: 2018-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2023
Title: Guanneng Yu: Innovator in Pharmaceutical Synthesis
Introduction
Guanneng Yu is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of methods for synthesizing complex compounds. His innovative approaches have led to advancements in the production of important pharmaceutical products.
Latest Patents
Guanneng Yu holds 2 patents related to the synthesis of Eliglustat and its intermediate compounds. His latest patents include a method for synthesizing Eliglustat and pharmaceutically acceptable salts thereof. This method utilizes novel synthetic intermediates and synthesis steps, which enhance operational ease, yield, and purity of both intermediates and target products. The advancements in his synthesis method facilitate industrial production, making it a valuable contribution to the pharmaceutical industry.
Career Highlights
Guanneng Yu is associated with Zhejiang Ausun Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical synthesis. His work has been instrumental in improving the efficiency and effectiveness of drug production processes. His innovative methods have garnered attention within the industry, showcasing his role as a key player in pharmaceutical research and development.
Collaborations
Guanneng Yu has collaborated with notable colleagues, including Yu Liu and Zhiguo Zheng. These collaborations have further enriched his research and contributed to the successful development of his patented methods.
Conclusion
Guanneng Yu's contributions to pharmaceutical synthesis exemplify the impact of innovation in the field. His patents and collaborative efforts highlight his commitment to advancing drug production methods. His work continues to influence the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile